Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Syphilis Update 2025
Description
In a presentation on syphilis at a medical conference, Professor Aaron Amerson provided an update on recent epidemiological trends, clinical presentations, and diagnostic improvements for syphilis in the U.S. He highlighted the resurgence of syphilis rates, particularly since 2011, with a notable increase in cases since 2020. Although primary and secondary syphilis rates showed a slight decline in 2023, disparities persist, especially among men who have sex with men and Native American populations, where there has been a staggering rise in congenital syphilis cases. Factors attributed to the increase include public health worker focus on COVID-19, increases in unprotected sex, and social determinants of health like poverty and homelessness. Amerson emphasized the need for clinicians to recognize various clinical presentations of syphilis, including atypical forms and neuro-syphilis, underlining the importance of screening and timely treatment. He discussed the latest testing protocols, including the shift to treponemal tests, and concluded with key take-home messages about rising rates, health disparities, and the importance of ongoing vigilance in recognizing and treating syphilis.
View moreConclusions
- Syphilis rates have rapidly increased in the US, affecting both men and women, with significant disparities in certain populations, particularly Native communities.
- The rise in congenital syphilis cases is concerning, indicating failures in prevention and treatment, especially among pregnant women.
- There are notable racial and ethnic disparities in syphilis rates, pointing to broader issues of health equity.
- Syphilis can present in multiple atypical clinical forms, necessitating vigilance in diagnosis.
- Patients suspected of having syphilis should be assessed for neurological symptoms, including vision and hearing issues.
- High-risk populations, including MSM and those living with HIV, should be regularly screened for syphilis and other STIs.
- JAMA Dermatology November 2022 Volume 158, Number 11
- Jack P. Cossman, MD1; John B. Fournier, MD1 JAMA Dermatol. 2017;153(7):718-719. doi:10.1001/jamadermatol.2017.0460
- Tuddenham et al JAMA 2022
- Muhammad Hyder Junejo 0,1 Mark Collery,2 Gary Whitlock,1 Alan McOwan,1 Junejo MH, et al. Sex Transm Infect 2021;0:1-3. doi:10.1136/
- Hicks CB. Diagnostic Testing for Syphilis. UpToDate.com. Accessed 2/20/2017.
- JAMA January 11, 2022 Volume 327, Number 2
- ARCH DERMATOL/VOL 148 (NO. 11), NOV 2012 1317-1322
- Clinical and Experimental Dermatology, 35, 169-172